The EU Commission market-tests commitments offered by an influenza vaccine manufacturer to address preliminary concerns of misleading disparagement of a rival's vaccine in the immunisation sector (Sanofi)
In its ongoing investigation of Sanofi for the alleged disparagement of a rival vaccine (see, Van Bael & Bellis Life Sciences News and Insights of 29 June 2026), the European Commission (Commission) published a communication on 8 July 2026 summarising its preliminary assessment that Sanofi may have abused its dominant position (the Communication). The Commis
